Not checked for notices yet.
IMPACT STUDY: MK-0646 (DALOTUZUMAB), INSULIN GROWTH FACTOR 1 RECEPTOR (IGF-1R) ANTIBODY COMBINED WITH PEMETREXED AND CISPLATIN IN STAGE IV METASTATIC NON-SQUAMOUS LUNG CANCER
Chao H Huang, Chao H Huang, Stephen K Williamson and 11 more
Frontiers in Oncology · 2016
Cited by papers we hold 1
- Therapeutic Targeting of the IGF Axis · 2019No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.